Table 5.

Hazard ratio of SMN.

	SMN (N = 62)
	Unadjusted HR (95% CI)	Adjusted HR (95% CI)
Sexa
Female	1	1
Male	0.9 (0.5–1.5)	0.7 (0.4–1.2)
Type of original cancerb
Lymphoma	1	1
Germ cell tumor	0.4 (0.2–0.9)*	0.5 (0.2–1.1)
Melanoma	0.3 (0.1–0.7)*	0.3 (0.1–0.6)*
Carcinoma (except of skin)	0.3 (0.1–0.5)*	0.2 (0.1–0.5)*
Othersc	0.3 (0.1–0.7)*	0.3 (0.1–0.7)*
Diagnosis periodd
1970–1979	1	1
1980–1989	1.5 (0.8–2.7)	1.5 (0.8–2.8)
1990–1995	1.8 (0.6–5.1)	1.7 (0.6–5)
Relapse < 5 years after diagnosise
No	1	1
Yes	1.9 (0.8–4.3)	1.2 (0.5–2.9)
Having chemotherapyf
No	1	1
Yes	1.9 (1.1–3.3)*	1.3 (0.7–2.5)
Having radiationf
No	1	1
Yes	2.9 (1.8–4.9)*	2.0 (1.1–3.7)*
Having surgeryf
No	1	1
Yes	0.8 (0.5–1.5)	1.4 (0.7–2.7)

*P < 0.05.

^aMultivariate analyses adjusted for type of original cancer, diagnosis period, and relapse < 5 years after diagnosis.

^bMultivariate analyses adjusted for sex, diagnosis period, and relapse < 5 years after diagnosis.

^cOther types of original cancers include leukemia, CNS, bone tumor, soft tissue sarcoma, and miscellaneous-specified tumor.

^dMultivariate analyses adjusted for sex, type of original cancer, and relapse < 5 years after diagnosis.

^eMultivariate analyses adjusted for sex, type of original cancer, and diagnosis period.

^fMultivariate analyses adjusted for sex, type of original cancer, diagnosis period, and relapse < 5 years after diagnosis.